This inventor holds 1 USPTO granted patent. Top assignee: Sorrento Therapeutics, Inc.. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Ingale Sampat Lalaso: Innovator in Intracellular Delivery Compounds
Introduction
Ingale Sampat Lalaso is a notable inventor based in San Diego, California. He has made significant contributions to the field of pharmaceutical sciences, particularly in the area of intracellular delivery systems. His work focuses on enhancing the efficacy of therapeutic agents through innovative delivery methods.
Latest Patents
Ingale Sampat Lalaso holds a patent for "Intracellular delivery compounds." This patent includes compounds having the Formula I, along with pharmaceutically acceptable salts and pharmaceutical compositions. The primary application of these compounds is in the intracellular delivery of antibodies, which is crucial for advancing therapeutic interventions.
Career Highlights
Ingale is currently associated with Sorrento Therapeutics, Inc., where he continues to develop groundbreaking solutions in drug delivery. His expertise in the field has positioned him as a valuable asset to the company and the broader scientific community.
Collaborations
Ingale has collaborated with esteemed colleagues, including Yanwen Fu and Gunnar Jörg Floris Kaufmann. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Ingale Sampat Lalaso's contributions to intracellular delivery compounds exemplify the importance of innovation in pharmaceutical sciences. His work not only advances therapeutic applications but also showcases the potential of collaborative efforts in research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile